Talecris to announce expansion, shares company results

Talecris Biotherapeutics on Friday is expected to announce a plan to expand its plant in North Carolina. The first phase of the expansion is anticipated to be a $280 million facility for the separation of blood plasma proteins used in drug development. The company also reported an increase in revenue and profit during the third quarter, owing to sales of its blood plasma-derived drug products.

View Full Article in:

News & Observer (Raleigh, N.C.), The · News & Observer (Raleigh, N.C.), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
CT
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Senior Counsel – Regulatory Affairs
RAI Services Company
Winston-Salem, NC